Solid Biosciences Inc. (NASDAQ:SLDB)
Bands
Volume
200 SMA
50 SMA
20 SMA
Videos
Alerts
Articles
Events
Old Forum Content for SLDB
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- woodman: This is a list of #Gene editing/therapy #Car-T stocks (#Biotech subset). I haven't updated it in some time, so it's not an up-to-date/complete list, but it provides a number stocks that are acting very well and, if you've paid any attention to this area over the years, you'll certainly recognize many of them (including $NTLA which @Dan added to his list today). If interested, kick some of their tires over the weekend (listed below in order of performance today). $ABEO $ADVM $EIGR $PGEN $QURE $RARE $AGTC $SRNE $BLUE $PRTA $CLLS $AVRO $MGTX $ADAP $KRYS $SRPT $BMRN $AMGN $ARCT $RGNX $CNCR $SLDB $TCRT $AGIO $NVS $JNJ $PFE $IOVA $NTLA $SGMO $LUMO $EDIT $VYGR $ORTX $CRSP $BLCM $BBIO
- Hemal: $SLDB 12/6/20 SLDB stock thoughts https://youtu.be/TUYj32yfh2M via @YouTube
- Sher: $SLDB - Hope no one is still in this... Solid Bio down 59% pre-market on another clinical hold on DMD gene therapy Nov. 12, 2019 7:18 AM ET|About: Solid Biosciences Inc. (SLDB)|By: Douglas W. House, SA News Editor Solid Biosciences (NASDAQ:SLDB) reports that the FDA has placed its Phase 1/2 clinical trial, IGNITE DMD, evaluating lead gene therapy candidate SGT-001 in Duchenne muscular dystrophy (DMD) patients on clinical hold after a participant experienced a serious adverse event related to the study drug.
- djmurph: $SLDB Looks like it might be bouncing off the 50 MA.
- GOOSE: TRADE: $SLDB STC STOCK @10.05 All of it. In cash 98% First time in years. A great day today.
- GOOSE: A TRADE: Added $SLDB BTO STOCK @11.17
- GOOSE: A TRADE: $SLDB BTO STOCK @11.14 An add to.
- Reif99: @GOOSE $SLDB You've had anice trade in this one. You're long from about $8, right?
- GOOSE: @Reif99 $SLDB Yah, you're right, but with my adding along the way my average is about 10.60.
- GOOSE: A TRADE: $SLDB BTO STOCK 11.66
- GOOSE: $SLDB Up .77 AH Long
- GOOSE: A TRADE: Added a 1/2 position to my full one. $SLDB BTO STOCK @11.36 Walking away from me soooo.......sorry DocS for the dots. ;>)
- GOOSE: $SLDB Hit a new high today since it had its big drop in early February. Long, full position, will add a little more on any pull backs.
- GOOSE: A TRADE: $SLDB STC STOCK @10.25 Didn't want to wait for a gap and crap.
- GOOSE: A TRADE: I'm slithering back into this one, sold all this morning @10.26 $SLDB BTO STOCK @9.69 1/2 Position
- GOOSE: A TRADE: Added some on the pull back. $SLDB BTO STOCK @8.51 Now a position and a half. Recent falling knife. Stop in place, mental. ;>)
- GOOSE: $SLDB Just ran from 8.40 - 9.00 in just a few minutes????? ;>)
- CraigReynolds: @GOOSE $SLDB Focused on half time CNBC at that time. Interesting how stocks move when mentioned.
- GOOSE: $SLDB UP .42 AH
- issues: @GOOSE $SLDB Others in that bio sector include $AEZS and $BDSI. np in any If I owned SLDB I wouldn't have enough confidence to hold very long. At the first drop I'd sell it.
- GOOSE: @issues $SLDB $AEZS $BDSI Thanks for your thoughts @issues, but I like the stock, BUT, like any stock, a lot depends on the market too. I'm keeping a tight grip on it, and I looking at my stuff most of the day, so it would have to be real sneaky to hurt me. ;>) It has been beaten down already, so any more action, can't hurt it too much. Have a great day tomorrow. GOOSE
- GOOSE: @bRobert $HIIQ $SLDB Hey, that's sweet. Thanks. Have a great day.
- GOOSE: $SLDB Not a recommendation, just FYI, $SLDB acted very well today, seems to be holding its high. on decent volume, and wasn't all over the place, just seemed to go up steadily. Wanted to add, and was patient, unusual for me, but it wouldn't let me in. I'll wait till the end of the day, and add some to round out my 3/4 position, to a full position. EDITED SYMBOL
- GOOSE: $SLDB Doesn't look like I'm going to get my fill. ;>(
- GOOSE: $SLDB Gave it to me with less than a minute to go. Now we'll see. Rounded out my full position. $SLDB BTO STOCK @8.74
- issues: @GOOSE $SLDB How in the world did you find this? I've never seen this one before!
- GOOSE: TRADE: $SLDB BTO STOCK @8.30 Long from below.
- Reif99: @GOOSE $SLDB You musta hadta limbo to buy below here ...
- GOOSE: A TRADE: I'm a 2 trickpony. ;>) $HIIQ & $SLDB $HIIQ STO 3/15/19 44.0 PUT @5.10 Will be out of all my $HIIQ TRADES by earnings next week.
- bRobert: @GOOSE $HIIQ $SLDB You're always horsing around. but you pony up when the going gets tough.
- GOOSE: A TRADE: Waited too long. $SLDB BTO STOCK 8.14 A recent falling knife.
- GOOSE: A TRADE: Falling knife, that I think has hit the butcher block. RISKY $SLDB STO 2/15/19 7.5 PUTS @.25 Worser comes to worser, I buy the stock for 7.25. ;>)
- efrain007: $SLDB might work over day high for a trade.
- efrain007: $SLDB working.... for now.
- debeers: $SLDB-Horrific. NP
- efrain007: @debeers $SLDB Not for a 59min trade ;)
- efrain007: $SLDB up 30% from low, if anyone played protect your profits use trailing stops.
- GOOSE: TRADES: Moth to the flame trade: $SLDB BTO STOCK @7.70 & 8.21 Giving it very little leeway. Jumping all over the place. Lady dB's mention.
- woodman: @steve71 $SRPT $PFE - I did see something about $PFE. Saw others speculating on something from $SLDB. Seems unlikely that, even if true, it would be a major threat to SRPT in the near term, though, doesn't it? What do you think?
- steve71: @woodman $SRPT $PFE $SLDB My guess is that after the $PFE data is public it will be a good time to buy $SRPT. Studies are apparently not on identical cohorts.
- woodman: @steve71 $SRPT $PFE $SLDB Thanks.
- Reif99: @woodman $SRPT $SLDB is apparently involved in that too, and is up 15%. I was in SLDB last month, brekout fake out, stopped watching it. Could have gotten in yesterday. Oh well.
- woodman: @Reif99 $SRPT $SLDB - yes SLDB in sympathy. I think it's decently behind SRPT in the process,, though.
- spmeyers: $SLDB craziest chart of the year? I bought the latest leg up last week
| Stock Price | $8.54 |
| Change | -2.62% |
| Volume | 378,947 |
Solid Biosciences Inc is a life science company engaged in developing therapies for Duchenne muscular dystrophy. Its product candidate, SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles.
Request Video of SLDBAlready a member? Sign in here.
Past Month
Leading Peers
-
$6.71 34.55%
-
$75.03 9.46%
-
$8.00 4.74%
Past Month
Lagging Peers
-
$10.00 -24.14%
-
$10.40 -21.54%
-
$13.04 -21.51%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!